Oncology & Hematology Coding Alert

Increase Revenue:

Payment Techniques for Heparin,Saline and Supplies

Medicare and private insurers consider most supply costs associated with chemotherapy administration (96400-96549) to be covered under the procedure's payment. Yet, oncology practices can get paid for supplies such as heparin and saline. Guidelines for Heparin and Saline Payment The key phrase associated with heparin (J1642) and saline (J7030-J7050) noncoverage is "at the same time." Although Medicare is clear that it will not pay for contemporaneous administration of saline and heparin, it does pay for the two supplies when given before or after chemotherapy delivery, says Stephanie Thompson, CPC, practice manager for Lexington Oncology Associates, an oncology practice in Kentucky. When used for hydration therapy to maintain line patency, both saline and heparin are covered. In addition, oncology practices may report a separate code to describe the administration of saline and heparin 90780-90781 (Therapeutic or diagnostic infusions). However, most Medicare carriers bundle heparin used to flush a port before chemotherapy administration by an implantable pump (96414 ... infusion technique, initiation of prolonged infusion [more than eight hours], requiring the use of a portable or implantable pump). Medicare maintains that administering fluids to ensure vascular access between courses of chemotherapy at the same session is essential for chemotherapy administration and is not separately billable. However, if a practice can show that a port flush is a distinct and separate service from the chemotherapy administration, heparin can also be billed. The same general rule applies when using saline to clean ports. If saline is used prior to the administration of the chemotherapy agent, you may bill for the cost of saline.

Medicare allows separate payment for saline or other intravenous solution used for hydration with or without chemotherapy. However, Medicare includes any saline or intravenous solution used for the chemotherapy drug administration in the infusion reimbursement. Although flushing a vascular access port before chemotherapy administration is integral to the procedure and not separately payable, if the patient makes a special visit to the physician's office for port flushing, report 99211 (Office or other outpatient visit ...). Private Payers May Pay for Other Supplies Because private payers' reimbursement policies vary, applying Medicare rules across-the-board could leave money on the table. Oncology practices may find that commercial payers often reimburse items such as needles and syringes (A4206-A4209). Among additional items that many non-Medicare insurers may pay for include: Blood tubing, arterial or venous (A4750) Surgical trays (A4550) Surgical trays are perhaps the most common item you can negotiate for payment, says Elaine Towle, CMPE, practice administrator for New Hampshire Oncology-Hematology in Hooksett. Commercial payers, especially managed care organizations, may provide less reimbursement than Medicare for the same procedures. So, with oncology practices getting less money but incurring the same costs, even small items such [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All